Cefpodoxime is a third-generation cephalosporin.
containing cefpodoxime proxetil (equivalent to 200 mg Cefpodoxime proxetil is chemically cefpodoxime base) were purchased from local pharmacy (RS)1(isopropoxycarbonyloxy)ethyl ( . Literature survey revealed that only a few automatic sample applicator, Hamilton syringe (100 µl), HPLC methods were reported for the estimation of Camag TLC Scanner 3, Camag Win CATS software, cefpodoxime proxetil in the biological fluids [2] [3] [4] [5] [6] . So far no Camag Twin-trough chamber (10 × 10 cm) and HPTLC method has been reported for the estimation of ultrasonicator were used during study. cefpodoxime proxetil in formulation. So authors have tried to develop accurate, precise and specific HPTLC method for the estimation of cefpodoxime proxetil.
Cefpodoxime proxetil working standard was procured as a gift sample from Necter Life Sciences, Chandigarh. Silica gel 60F 254 TLC plates (10 × 10 cm, layer thickness 0.2 mm, E. Merck, Mumbai) were used as a stationary phase. All chemicals and reagents used were of analytical grade. Chloroform:methanol:toluene (4:2:4 v/v/v) was used as mobile phase. Methanol was used as solvent. Tablets *For correspondence E-mail: nehal9175@yahoo.co.in Cefpodoxime proxetil (10 mg) was weighed accurately and transferred to a 10 ml volumetric flask. It was dissolved in and diluted up to mark with methanol. The solution (1 ml) was diluted further to 10 ml with methanol. The final solution contained 100 µg of cefpodoxime proxetil per ml of the solution. The content of twenty tablets were grounded to fine powder. The tablet powder equivalent to 25 mg of cefpodoxime proxetil was transferred to volumetric flask and dissolved in methanol. The solution was sonicated for 15 min. The extracts were filtered through Whatmann filter paper No. 41 and residue was washed with methanol. The extracts and washing were pooled and transferred to a 250 ml www.ijpsonline.com volumetric flask and volume was made up to 250 ml with methanol to get 100 µg/ml of cefpodoxime proxetil. TLC plates were prewashed with methanol. Activation of plates were done in an oven at 50 0 for 30 min. The chromatographic conditions maintained were precoated silica gel 60F 254 aluminum sheets (10×10 cm) as stationary phase, chloroform: methanol: toluene (4:2:4 v/v/v) as mobile phase, chamber and plate saturation time of 30 min, migration distance allowed was 72 mm, wavelength scanning was done at 289.0 nm keeping the slit dimension at 5×0.45 mm. A deuterium lamp provided the source of radiation. Cefpodoxime proxetil (5 µl standard solution) was spotted and developed at constant temperature. Photometric measurements were performed at 289.0 nm in reflectance mode with Camag TLC scanner 3 using Win CATS software.
Aliquots of 1, 2, 3, 4, 5, 6, and 7 µl of standard solution of was assessed by spotting 4 µl of drug solution 3 times on cefpodoxime proxetil were applied on the TLC plate (100 a TLC plate followed by development of plate and µg/ml of drug). TLC plate was dried, developed and recording the peak area for 5 spot. The % RSD for analyzed photometrically as described earlier. The peak area values of cefpodoxime proxetil was found to standard calibration curve was generated using regression be 0.45. Repeatability of measurement of peak area was determined by spotting 4 µl of cefpodoxime proxetil solution on a TLC plate and developing the plate. The The developed method was validated in terms of separated spot was scanned five times without changing linearity, accuracy, specificity, limit of detection, limit of the position of the plate and % RSD for measurement of quantification, intra-day and inter-day precision and peak area of cefpodoxime proxetil was 0.74. To confirm repeatability of measurement as well as repeatability of the specificity of the proposed method, the solution of sample application.
the formulation was spotted on the TLC plate, developed and scanned. It was observed that the excipients present Four microlitres of the filtered solutions of the marketed in the formulation did not interfere with the peaks of formulation was spotted on to the same plate followed by cefpodoxime proxetil. development scanning. The analysis was repeated in triplicate. The content of the drug was calculated from the Recovery studies of the drugs were carried out for the peak areas recorded. accuracy parameters. These studies were carried out at three levels i.e. multiple level recovery studies. Sample The mobile phase consisting of chloroform: methanol: stock solution from tablet formulation of 100 µg/ml of was toluene (4:2:4 v/v/v) gave R f values of 0.56 (±0.03) prepared. To the above prepared solutions, 50%, 100%
analysis.
cefpodoxime proxetil ( fig.1 ). The linear regression data (n=5) showed a good linear relationship over a concentration range of 100-700 ng/spot for cefpodoxime proxetil. The limit of detection and limit of quantification were found to be 30 ng/spot and 90 ng/spot, respectively.
The intra-day precision was determined by analyzing standard solutions in the concentration range of 200 ng/ spot to 600 ng/spot of each drug for 3 times on the same day while inter-day precision was determined by analyzing corresponding standards daily for 3 day over a period of one week. Repeatability of sample application and 150% of the standard drug solutions were added. Dilutions were made and recovery studies were performed. Percentage recovery was found to be within the limits as listed in Table 1 . The assay value for the marketed formulation was found to be within the limits as listed in Table 1 . The low RSD value indicated the suitability of the method for routine analysis of cefpodoxime proxetil in pharmaceutical dosage forms. The developed HPTLC technique is simple, precise, specific and accurate and the statistical analysis proved that method is reproducible and selective for the analysis of cefpodoxime proxetil in bulk drug and tablet formulations. 
